Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2019 Nov 13;160(1):261–271.e1. doi: 10.1016/j.jtcvs.2019.10.102

TABLE 4.

Multivariable analysis of factors associated risk of death in patients with resected pathologic T1–3 pN1–2 M0 non-small cell lung cancer

Hazard ratio 95% confidence interval (lower, upper) P value
Age (per decade) 1.15 (1.11, 1.20) <.001
Year of diagnosis (ref = 2006) 0.98 (0.97, 0.99) .005
Female sex 0.79 (0.75, 0.84) <.001
Race (ref = white)
 Black 0.99 (0.89, 1.10) .84
 Other 0.85 (0.72, 1.01) .06
Charlson Comorbidity Score (ref = 0)
 1 1.15 (1.08, 1.22) <.001
 2+ 1.26 (1.16, 1.37) <.001
Education (per quartile) 1.00 (0.96, 1.04) .97
Income (per quartile) 0.97 (0.93, 1.00) .052
Insurance status (ref = private)
 Medicare/Medicaid 1.20 (1.12, 1.29) <.001
 Other government 1.09 (0.81, 1.46) .58
 Unknown 1.08 (0.81, 1.44) .61
 Uninsured 1.36 (1.12, 1.64) .002
AJCC pathologic T stage 1.24 (1.19, 1.28) <.001
AJCC pathologic N2 (vs Nl) 1.40 (1.32, 1.50) <.001
Pneumonectomy (vs lobectomy) 1.06 (0.98, 1.16) .14
Length of stay (per day) 1.02 (1.02, 1.03) <.001
Readmission 1.25 (1.11, 1.41) <.001
Facility type (ref = community)
 Comprehensive community program 0.84 (0.76, 0.93) .001
 Research/academic program 0.76 (0.68, 0.84) <.001
Guideline-concordant adjuvant therapy 0.66 (0.62, 0.70) <.001

AJCC, American Joint Committee on Cancer.